Drugs / SB732461
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00434512 | Feb 2007 → Jun 2008 | AIDS | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB732461 | “Healthy adult HIV seronegative subjects aged 18 to 40 years, who received two doses of the adjuvanted low-antigen dose \[LD\] (10 μg) SB732461 vaccine, intramuscularly, at Day...” NCT00434512 ↗ |
| Modality | Vaccine | “HIV vaccine 732461” NCT00434512 ↗ |
| Route | Intramuscular | “SB732461 vaccine, intramuscularly” NCT00434512 ↗ |